Analysis of curative effect of chondroitin sulfate and glucnsamine sulfate on Kaschin-Beck disease
10.3760/cma.j.issn.1000-4955.2010.01.027
- VernacularTitle:硫酸软骨素和硫酸氨基葡萄糖对成人大骨节病的疗效分析
- Author:
Hui, LIU
;
Wei, DONG
;
Ya-xu, ZHANG
;
Qing, DENG
;
Jiu-cheng, SONG
;
Ben, GAO
;
Ning, LIU
;
Yun-qi, LIU
- Publication Type:Journal Article
- Keywords:
Kaschin-Beck disease;
Knee joint;
X-rays;
Chondroitin sulfate;
Ghcosamine sulfate
- From:Chinese Journal of Endemiology
2010;29(1):98-100
- CountryChina
- Language:Chinese
-
Abstract:
Objective To research the curative effect of chondroitin sulfate and glucosamine on Kashin-Beck disease(KBD). Methods According to Diagnosis for Kashin-Beck disease,80 patients of adult KBD were detected from Guanghui village Shangzhi city Heilongjiang province in July,2007,and they divided into treatment group and control group according to their condition,age and sex,40 person in each group. Treatment group was given chondroitin sulfate and glucosamine sulfate,and control group was given placebo(equivalent amount of starch). Bilateral knees X-ray films were shot before and after treatment (8th month),scale division magnifying glass was used to measure the width of joint space on X-ray films. Results The width of joint space respectively was (4.30±2.14) and (4.10±2.07)mm in control group before and after treatment,and treatment group respectively was (4.17±2.15),(4.16±2.11)mm. Medicine had no obviously role on joint space (F = 0.50,P > 0.05),Time and both of time and medicine had obvious role on joint space(F= 67.66,46.74,all P< 0.05). Joint space of treat group was thinner than control group(P < 0.05) before treatment,but thicker after treatment(P < 0.05). To compare with the width of before treatment,joint space width of control group became obviously narrow(P < 0.05). Conclusions Experimental group taking chondroitin sulfate and glucosamine sulfate alleviated knee joint space narrowing process of adults KBD patients compared with control group. It plays a protection role in articular cartilage and provides evidences for choosing drug and evaluating effect in the treatment of adults KBD.
